Cold & Cough Remedies (Pharmacies) - Italy

Revenue in the Cold & Cough Remedies market is projected to reach US$686.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.18%, resulting in a market volume of US$802.40m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$11.69 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Italy has been experiencing steady growth in recent years.

Customer preferences: Italian consumers have a high demand for cold and cough remedies, particularly during the winter months when cold and flu season is at its peak. This is driven by the desire to alleviate symptoms such as coughing, sneezing, and congestion. Customers are also increasingly seeking natural and herbal remedies, as they are perceived to be safer and have fewer side effects compared to traditional pharmaceutical products.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Italy is the increasing popularity of over-the-counter (OTC) products. These products are easily accessible and do not require a prescription, making them convenient for consumers. Additionally, the rising health consciousness among Italians has led to an increased demand for natural and organic cold and cough remedies. This trend is driven by the perception that natural remedies are more effective and have fewer side effects compared to traditional pharmaceutical products. Another trend in the market is the growing preference for combination products. These products offer multiple benefits in a single dose, such as relieving cough, congestion, and sore throat. Combination products are particularly popular among busy individuals who prefer the convenience of a single medication to address multiple symptoms.

Local special circumstances: Italy has a well-established healthcare system, which includes a network of pharmacies that play a crucial role in distributing cold and cough remedies. Pharmacies in Italy are easily accessible to consumers and provide a wide range of products, including both prescription and OTC medications. This accessibility and availability of cold and cough remedies contribute to the growth of the market.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies (Pharmacies) market in Italy is also influenced by macroeconomic factors. Italy has a large aging population, which is more susceptible to respiratory illnesses and therefore has a higher demand for cold and cough remedies. Additionally, the rising disposable income among Italians has increased their purchasing power and ability to afford these products. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Italy is growing due to customer preferences for OTC and natural remedies, as well as the convenience and accessibility provided by pharmacies. The market is also influenced by the trend of combination products and the underlying macroeconomic factors such as the aging population and rising disposable income.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.